PACIRA制药

PCRX NASDAQ
43.81
+1.03
+2.41%
交易中 15:13 06/18 EDT
开盘
42.89
昨收
42.78
最高
44.58
最低
42.56
成交量
19.40万
成交均量(3M)
56.67万
52周最高
55.00
52周最低
30.00
换手率
0.47%
市值
18.09亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供PACIRA制药 PCRX股票价格,PACIRA制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Pacira BioSciences, Inc., formerly Pacira Pharmaceuticals, Inc. is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists of bupivacaine, an amide-type local anesthetic, encapsulated in DepoFoam and is indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. In addition to EXPAREL, DepoFoam is also the basis for its other Food and Drug Administration-approved commercial product, DepoCyt(e), which it manufactures for its commercial partners, as well as its product candidates. The Company's other product candidates include DepoMeloxicam (DepoMLX) and DepoTranexamic Acid (DepoTXA).
展开 >

最近浏览

名称
价格
涨跌幅